Completed in 2021 in Cambridge, United Kingdom. Images by Hufton+Crow. AstraZeneca is establishing a new global research and development facility, named The Discovery Centre (DISC) in Cambridge, UK, on the Cambridge...
The Discovery Centre is designed to foster collaboration and interaction – helping us accelerate the development of medicines for patients. This state-of-the-art building, the novel technologies and talented scientists it houses, will help us sustain and build the next wave of transformational ...
AstraZeneca has established a new global research and development facility, named The Discovery Centre (DISC) in Cambridge, UK, on the Cambridge Biomedical Campus (CBC). The CBC plays an important role in the UK and Europe’s leading life sciences cluster. It is a hub...
The Discovery Centre in Cambridge (UK) is one of our global science centres Explore all our science centres Sustainability at AstraZeneca Corporate Press Release Datopotamab deruxtecan application in the EU for patients with advanced nonsquamous non-small cell lung cancer voluntarily withdrawn ...
AstraZeneca's Discovery Centre by Herzog de Meuron is inaugurated in Cambridge, a new research and development hub with a suitably advanced design
In 2003 a £27m safety assessment laboratory for drug safety testing was constructed. In 2006, with AstraZeneca’s largest investment at the site, a £60.9m cancer research building known as the global advanced lead discovery centre was completed. ...
AstraZenecais a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines in Oncology, Rare Diseases and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based inCambridge, UK,...
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines in Oncology, Rare Diseases and BioPharmaceuticals, including Cardiovascular, Renal...
Please check your connection, disable any ad blockers, or try using a different browser.
AstraZeneca (LSE/STO/NYSE: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Onc...